Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Robert Szczepaniak-Sloane"'
Autor:
Miles C. Andrews, Junna Oba, Chang-Jiun Wu, Haifeng Zhu, Tatiana Karpinets, Caitlin A. Creasy, Marie-Andrée Forget, Xiaoxing Yu, Xingzhi Song, Xizeng Mao, A. Gordon Robertson, Gabriele Romano, Peng Li, Elizabeth M. Burton, Yiling Lu, Robert Szczepaniak Sloane, Khalida M. Wani, Kunal Rai, Alexander J. Lazar, Lauren E. Haydu, Matias A. Bustos, Jianjun Shen, Yueping Chen, Margaret B. Morgan, Jennifer A. Wargo, Lawrence N. Kwong, Cara L. Haymaker, Elizabeth A. Grimm, Patrick Hwu, Dave S. B. Hoon, Jianhua Zhang, Jeffrey E. Gershenwald, Michael A. Davies, P. Andrew Futreal, Chantale Bernatchez, Scott E. Woodman
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
The regulation of the distinct intrinsic phenotypic states in melanoma remain poorly characterised. Here, multi-omics analysis for a panel of 68 early passage melanoma cell lines reveals that cancer cell intrinsic transcriptomic programs are associat
Externí odkaz:
https://doaj.org/article/96b59787498043a5a256fe86f8315695
Autor:
Michael G. White, Robert Szczepaniak Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews, Ningping Feng, Sarah Johnson, Caleb A. Class, Christopher Bristow, Khalida Wani, Courtney Hudgens, Luigi Nezi, Teresa Manzo, Mariana Pettaccia De Macedo, Jianhua Hu, Richard Davis, Hong Jiang, Peter Prieto, Elizabeth Burton, Patrick Hwu, Hussein Tawbi, Jeffrey Gershenwald, Alexander J. Lazar, Michael T. Tetzlaff, Willem Overwijk, Scott E Woodman, Zachary A. Cooper, Joseph R. Marszalek, Michael A. Davies, Timothy P. Heffernan, Jennifer A. Wargo
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Targeted and immunotherapy regimens have revolutionized the treatment of advanced melanoma patients. Despite this, only a subset of patients respond durably. Recently, combination strategies of BRAF/MEK inhibitors with immune checkpoint inhibitor mon
Externí odkaz:
https://doaj.org/article/e6152b9f5495402183474ea2dacf7022
Autor:
Alexandre Reuben, Christine N. Spencer, Peter A. Prieto, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, John P. Miller, Xizeng Mao, Mariana Petaccia De Macedo, Jiong Chen, Xingzhi Song, Hong Jiang, Pei-Ling Chen, Hannah C. Beird, Haven R. Garber, Whijae Roh, Khalida Wani, Eveline Chen, Cara Haymaker, Marie-Andrée Forget, Latasha D. Little, Curtis Gumbs, Rebecca L. Thornton, Courtney W. Hudgens, Wei-Shen Chen, Jacob Austin-Breneman, Robert Szczepaniak Sloane, Luigi Nezi, Alexandria P. Cogdill, Chantale Bernatchez, Jason Roszik, Patrick Hwu, Scott E. Woodman, Lynda Chin, Hussein Tawbi, Michael A. Davies, Jeffrey E. Gershenwald, Rodabe N. Amaria, Isabella C. Glitza, Adi Diab, Sapna P. Patel, Jianhua Hu, Jeffrey E. Lee, Elizabeth A. Grimm, Michael T. Tetzlaff, Alexander J. Lazar, Ignacio I. Wistuba, Karen Clise-Dwyer, Brett W. Carter, Jianhua Zhang, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Zachary A. Cooper, Jennifer A. Wargo
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-11 (2017)
Melanoma: Tumor differences within a patient may explain heterogeneous responses Patients with metastatic melanoma display molecular and immune differences across tumor sites associated with differential drug responses. A team led by Jennifer Wargo f
Externí odkaz:
https://doaj.org/article/95f4f8da81aa4220b7ea3fea4b7af4b6
Autor:
Hannah Wollenzien, Yohannes Afeworki A. Tecleab, Robert Szczepaniak-Sloane, Anthony Restaino, Michael S. Kareta
Publikováno v:
Molecular Cancer Research.
Small Cell Lung Cancer (SCLC) is often a heterogeneous tumor, where dynamic regulation of key transcription factors can drive multiple populations of phenotypically different cells which contribute differentially to tumor dynamics. This tumor is char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05fff611b384373722261d35de866b13
https://doi.org/10.1158/1541-7786.mcr-22-0881
https://doi.org/10.1158/1541-7786.mcr-22-0881
Autor:
Hannah Wollenzien, Yohannes Afeworki, Robert Szczepaniak-Sloane, Anthony Restaino, Michael S. Kareta
Small Cell Lung Cancer (SCLC) is often a heterogeneous tumor, where dynamic regulation of key transcription factors can drive multiple populations of phenotypically different cells which contribute differentially to tumor dynamics. This tumor is char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05c29b5f2d17a2459e646ec6f55aa59d
https://doi.org/10.1101/2022.10.20.513051
https://doi.org/10.1101/2022.10.20.513051
Autor:
Carlos A. Torres-Cabala, Ignacio I. Wistuba, Kumaran Mudaliar, Jing Ning, Daniel H. Johnson, Saira George, Sandesh Subramanya, Robert Szczepaniak-Sloane, Jennifer A. Wargo, Courtney W. Hudgens, Alexandre Reuben, Chi H Lee, Adi Diab, Denái R. Milton, Michael T. Tetzlaff, Jonathan L. Curry, Victor G. Prieto
Publikováno v:
Journal of Cutaneous Pathology. 46:627-636
BACKGROUND Cancer patients receiving antibodies abrogating immune checkpoint pathways may develop a diverse array of immune-related adverse events (irAEs), of which lichenoid dermatitis (LD) is the most common. The mechanism driving the emergence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4e503a068e5a6f2a8363fcca44a4247
https://doi.org/10.1111/cup.13454
https://doi.org/10.1111/cup.13454
Autor:
Jonathan L, Curry, Alexandre, Reuben, Robert, Szczepaniak-Sloane, Jing, Ning, Denái R, Milton, Chi H, Lee, Courtney, Hudgens, Saira, George, Carlos, Torres-Cabala, Daniel, Johnson, Sandesh, Subramanya, Jennifer A, Wargo, Kumaran, Mudaliar, Ignacio I, Wistuba, Victor G, Prieto, Adi, Diab, Michael T, Tetzlaff
Publikováno v:
Journal of cutaneous pathologyREFERENCE. 46(9)
Cancer patients receiving antibodies abrogating immune checkpoint pathways may develop a diverse array of immune-related adverse events (irAEs), of which lichenoid dermatitis (LD) is the most common. The mechanism driving the emergence of these irAEs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::641f38c46a0211cdeaf98bb83480ae9b
https://pubmed.ncbi.nlm.nih.gov/30883858
https://pubmed.ncbi.nlm.nih.gov/30883858